ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 150,800
+1,300 (0.87%)
Mar 20, 2026, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 3.13 trillion as of March 20, 2026. Its market cap has increased by 87.76% in one year.
Market Cap
3.13T
Enterprise Value
3.09T
Revenue
318.32B
Ranking
n/a
PE Ratio
84.00
Stock Price
150,800.00
Market Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 3.13T, an increase of 247.34%. That is a compound annual growth rate of 13.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.13T | 26.97% |
| Dec 30, 2025 | 2.47T | 37.85% |
| Dec 30, 2024 | 1.79T | 40.37% |
| Dec 28, 2023 | 1.28T | -22.60% |
| Dec 29, 2022 | 1.65T | -36.55% |
| Dec 30, 2021 | 2.60T | 34.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.46T |
| Celltrion | 45.86T |
| ALTEOGEN | 18.96T |
| Sam Chun Dang Pharm. | 18.23T |
| OliX Pharmaceuticals | 3.77T |
| D&D Pharmatech | 3.64T |
| CLASSYS | 3.56T |
| SK bioscience | 3.43T |